Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
|
JAMA
|
2005
|
4.46
|
2
|
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
|
Circulation
|
2005
|
2.81
|
3
|
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study.
|
BMJ
|
2012
|
2.65
|
4
|
Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies.
|
Scand J Clin Lab Invest
|
2013
|
1.39
|
5
|
Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.
|
Int J Cardiol
|
2009
|
1.11
|
6
|
Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study.
|
Eur J Endocrinol
|
2009
|
1.08
|
7
|
Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study.
|
J Clin Endocrinol Metab
|
2014
|
1.00
|
8
|
IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population.
|
Eur J Endocrinol
|
2008
|
0.98
|
9
|
N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states.
|
Clin Endocrinol (Oxf)
|
2004
|
0.98
|
10
|
Patient preferences for diabetes management among people with type 2 diabetes in Denmark - a discrete choice experiment.
|
Curr Med Res Opin
|
2011
|
0.95
|
11
|
Reference methods for the measurement of free thyroid hormones in blood: evaluation of potential reference methods for free thyroxine.
|
Clin Biochem
|
2004
|
0.93
|
12
|
Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.
|
Endocrine
|
2012
|
0.91
|
13
|
Measuring elderly dysphagic patients' performance in eating--a review.
|
Disabil Rehabil
|
2011
|
0.89
|
14
|
Gestational age-specific reference ranges from different laboratories misclassify pregnant women's thyroid status: comparison of two longitudinal prospective cohort studies.
|
Eur J Endocrinol
|
2013
|
0.86
|
15
|
Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
|
Am J Cardiol
|
2012
|
0.84
|
16
|
Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial.
|
PLoS One
|
2013
|
0.83
|
17
|
The association between pressure pain sensitivity, and answers to questionnaires estimating psychological stress level in the workplace. A feasibility study.
|
Scand J Clin Lab Invest
|
2012
|
0.82
|
18
|
Pressure pain sensitivity: a new method of stress measurement in patients with ischemic heart disease.
|
Scand J Clin Lab Invest
|
2013
|
0.81
|
19
|
GH activity and markers of inflammation: a crossover study in healthy volunteers treated with GH and a GH receptor antagonist.
|
Eur J Endocrinol
|
2012
|
0.81
|
20
|
Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure.
|
Growth Horm IGF Res
|
2009
|
0.81
|
21
|
The LEAF questionnaire: a screening tool for the identification of female athletes at risk for the female athlete triad.
|
Br J Sports Med
|
2014
|
0.81
|
22
|
Plasma YKL-40 levels are elevated in patients with chronic heart failure.
|
Scand Cardiovasc J
|
2010
|
0.80
|
23
|
α-Defensins and outcome in patients with chronic heart failure.
|
Eur J Heart Fail
|
2012
|
0.80
|
24
|
Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population.
|
Inflamm Res
|
2010
|
0.80
|
25
|
Metabolic syndrome and mortality in stable coronary heart disease: relation to gender.
|
Int J Cardiol
|
2007
|
0.80
|
26
|
Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction.
|
BMC Cardiovasc Disord
|
2013
|
0.79
|
27
|
Peripheral markers of thyroid function: the effect of T4 monotherapy vs T4/T3 combination therapy in hypothyroid subjects in a randomized crossover study.
|
Endocr Connect
|
2013
|
0.79
|
28
|
Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes.
|
Eur J Heart Fail
|
2008
|
0.78
|
29
|
Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study.
|
Pituitary
|
2011
|
0.78
|
30
|
Prognostic value of NH2-terminal pro B-type natriuretic peptide in patients with diabetes and stable coronary heart disease.
|
Diabetes Care
|
2006
|
0.78
|
31
|
Prevalence and characteristics of diabetic patients in a chronic heart failure population.
|
Int J Cardiol
|
2005
|
0.78
|
32
|
Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure.
|
Scand Cardiovasc J
|
2010
|
0.78
|
33
|
Influence of adsorption and deproteination on potential free thyroxine reference methods.
|
Clin Chem
|
2002
|
0.78
|
34
|
A simple procedure for routine RNA extraction and miRNA array analyses from a single thyroid in vivo fine needle aspirate.
|
Scand J Clin Lab Invest
|
2010
|
0.77
|
35
|
The association between changes in pressure pain sensitivity and changes in cardiovascular physiological factors associated with persistent stress.
|
Scand J Clin Lab Invest
|
2013
|
0.77
|
36
|
Validation of the Danish version of the McGill Ingestive Skills Assessment using classical test theory and the Rasch model.
|
Disabil Rehabil
|
2011
|
0.77
|
37
|
Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
|
Metabolism
|
2013
|
0.77
|
38
|
Characteristics and reference ranges of Insulin-Like Growth Factor-I measured with a commercially available immunoassay in 724 healthy adult Caucasians.
|
Scand J Clin Lab Invest
|
2009
|
0.77
|
39
|
N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbances.
|
Clin Endocrinol (Oxf)
|
2007
|
0.76
|
40
|
Short-term teriparatide treatment does not affect NT-proBNP, a marker of cardiac disease.
|
Scand J Clin Lab Invest
|
2012
|
0.76
|
41
|
Iodine-based contrast media cause hyperthyroidism - another important adverse reaction to contrast media?
|
Acta Radiol
|
2012
|
0.75
|
42
|
New-onset atrial fibrillation is a predictor of subsequent hyperthyroidism: a nationwide cohort study.
|
PLoS One
|
2013
|
0.75
|
43
|
Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides.
|
Pituitary
|
2010
|
0.75
|
44
|
Content validation of a Danish version of "The McGill Ingestive Skills Assessment" for dysphagia management.
|
Scand J Occup Ther
|
2010
|
0.75
|
45
|
Reliability of the Danish version of the McGill Ingestive Skills Assessment for observation-based measures during meals.
|
Scand J Occup Ther
|
2012
|
0.75
|
46
|
Association between pressure pain sensitivity and autonomic function as assessed by a tilt table test.
|
Scand J Clin Lab Invest
|
2015
|
0.75
|
47
|
Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes.
|
Diabetologia
|
2015
|
0.75
|
48
|
Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?
|
J Hypertens
|
2017
|
0.75
|
49
|
N-terminal-pro-B-type natriuretic peptide in acute hyperthyroidism.
|
Thyroid
|
2007
|
0.75
|
50
|
Reduced Neuromuscular Performance in Amenorrheic Elite Endurance Athletes.
|
Med Sci Sports Exerc
|
2017
|
0.75
|